The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance
Open accessAbstract
BACKGROUND: With an increase in the use of colistin methansulfonate (CMS) to treat carbapenem-resistant Acinetobacter baumannii infections, colistin resistance is emerging. METHODS: Patients with infection or colonization due to colistin-resistant A. baumannii were identified at a hospital system in Pennsylvania. Clinical data were collected from electronic medical records. Susceptibility testing, pulsed-field gel electrophoresis (PFGE), and multilocus sequence typing (MLST) were performed. To investigate the mechanism of colistin resistance, lipid A was subjected to matrix-assisted laser desorption/ionization mass spectrometry. RESULTS: Twenty patients with colistin-resistant A. baumannii were identified. Ventilator-associated pneumonia was the most common type of infection. Nineteen patients had received intravenous and/or inhaled CMS for treatment of carbapenem-resistant, colistin-susceptible A. baumannii infection prior to identification of colistin-resistant isolates. The 30-day all-cause mortality rate was 30%. The treatment regimen for colistin-resistant A. baumannii infection associated with the lowest mortality rate was a combination of CMS, a carbapenem, and ampicillin-sulbactam. The colistin-susceptible and -resistant isolates from the same patients were highly related by PFGE, but isolates from different patients were not, suggesting evolution of resistance during CMS therapy. By MLST, all isolates belonged to the international clone II, the lineage that is epidemic worldwide. Phosphoethanolamine modification of lipid A was present in all colistin-resistant A. baumannii isolates. CONCLUSIONS: Colistin-resistant A. baumannii occurred almost exclusively among patients who had received CMS for treatment of carbapenem-resistant, colistin-susceptible A. baumannii infection. Lipid A modification by the addition of phosphoethanolamine accounted for colistin resistance. Susceptibility testing for colistin should be considered for A. baumannii identified from CMS-experienced patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H., & Swaminathan, B. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.9.2233-2239.1995 · Cited by 8,204
Horan, T. C., Andrus, M., & Dudeck, M. A. (2008) · American Journal of Infection Control · doi:10.1016/j.ajic.2008.03.002 · Cited by 6,626
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Hidron, A. I., Edwards, J. R., Patel, J., Horan, T. C., Sievert, D. M., Pollock, D. A., Fridkin, S. K., & National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591861 · Cited by 3,724
Acinetobacter baumannii : Emergence of a Successful Pathogen
Peleg, A. Y., Seifert, H., & Paterson, D. L. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-07 · Cited by 3,316
Sievert, D. M., Ricks, P., Edwards, J. R., Schneider, A., Patel, J., Srinivasan, A., Kallen, A., Limbago, B., Fridkin, S., & National Healthcare Safety Network (NHSN) Team and Participating NHSN Facilities (2013) · Infection Control & Hospital Epidemiology · doi:10.1086/668770 · Cited by 1,582
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Li, J., Nation, R. L., Turnidge, J. D., Milne, R. W., Coulthard, K., Rayner, C. R., & Paterson, D. L. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70580-1 · Cited by 1,388
Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp.
WOODFORD, N., ELLINGTON, M., COELHO, J., TURTON, J., WARD, M., BROWN, S., AMYES, S., & LIVERMORE, D. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.01.004 · Cited by 1,117
Woodford, N., Turton, J. F., & Livermore, D. M. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00268.x · Cited by 885
Moffatt, J. H., Harper, M., Harrison, P., Hale, J. D. F., Vinogradov, E., Seemann, T., Henry, R., Crane, B., St. Michael, F., Cox, A. D., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00834-10 · Cited by 812
Diancourt, L., Passet, V., Nemec, A., Dijkshoorn, L., & Brisse, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010034 · Cited by 719
Bartual, S. G., Seifert, H., Hippler, C., Luzon, M. A. D., Wisplinghoff, H., & Rodríguez-Valera, F. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.9.4382-4390.2005 · Cited by 662
Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages
Zarrilli, R., Pournaras, S., Giannouli, M., & Tsakris, A. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.09.008 · Cited by 496
Pharmacology of Polymyxins: New Insights into an ‘Old‘ Class of Antibiotics
Velkov, T., Roberts, K. D., Nation, R. L., Thompson, P. E., & Li, J. (2013) · Future Microbiology · doi:10.2217/fmb.13.39 · Cited by 452
Beceiro, A., Llobet, E., Aranda, J., Bengoechea, J. A., Doumith, M., Hornsey, M., Dhanji, H., Chart, H., Bou, G., Livermore, D. M., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00079-11 · Cited by 379
Arroyo, L. A., Herrera, C. M., Fernandez, L., Hankins, J. V., Trent, M. S., & Hancock, R. E. W. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00256-11 · Cited by 275
Karah, N., Sundsfjord, A., Towner, K., & Samuelsen, Ø. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.06.001 · Cited by 264
Multiresistant Acinetobacter baumannii infections: epidemiology and management
Garnacho-Montero, J., & Amaya-Villar, R. (2010) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32833ae38b · Cited by 236
Rhomberg, P. R., & Jones, R. N. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.08.020 · Cited by 195
Pelletier, M. R., Casella, L. G., Jones, J. W., Adams, M. D., Zurawski, D. V., Hazlett, K. R. O., Doi, Y., & Ernst, R. K. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00865-13 · Cited by 175
Self-citationLesho, E., Yoon, E.-J., McGann, P., Snesrud, E., Kwak, Y., Milillo, M., Onmus-Leone, F., Preston, L., St. Clair, K., Nikolich, M., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit293 · Cited by 171
Adams‐Haduch, J. M., Paterson, D. L., Sidjabat, H. E., Pasculle, A. W., Potoski, B. A., Muto, C. A., Harrison, L. H., & Doi, Y. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00570-08 · Cited by 145
Self-citationMolecular Epidemiology of Carbapenem-Nonsusceptible Acinetobacter baumannii in the United States
Adams‐Haduch, J. M., Onuoha, E. O., Bogdanovich, T., Tian, G., Marschall, J., Urban, C. M., Spellberg, B. J., Rhee, D., Halstead, D. C., Pasculle, A. W., et al. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00619-11 · Cited by 127
Self-citationCarbapenem-resistantAcinetobacter baumannii: epidemiology, surveillance and management
Pogue, J. M., Mann, T., Barber, K. E., & Kaye, K. S. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.13.14 · Cited by 121
López-Rojas, R., McConnell, M. J., Me, J.-M., Domínguez-Herrera, J., Fernández-Cuenca, F., & Pachón, J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00543-13 · Cited by 88
Queenan, A. M., Pillar, C. M., Deane, J., Sahm, D. F., Lynch, A. S., Flamm, R. K., Peterson, J., & Davies, T. A. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.04.002 · Cited by 84
Reddy, T., Chopra, T., Marchaim, D., Pogue, J. M., Alangaden, G. J., Salimnia, H., Boikov, D. A., Navon‐Venezia, S., Akins, R. A., Selman, P., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01665-09 · Cited by 81
Eighteen Years of Experience With Acinetobacter baumannii in a Tertiary Care Hospital*
Munoz-Price, L. S., Arheart, K. L., Nordmann, P., Boulanger, A. E., Cleary, T., Alvarez, R., Pizano, L. R., Namias, N., Kett, D. H., & Poirel, L. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e318298a541 · Cited by 75
O’Hara, J. A., Ambe, L. A., Casella, L. G., Townsend, B. M., Pelletier, M. R., Ernst, R. K., Shanks, R. M. Q., & Doi, Y. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02501-12 · Cited by 73
Self-citationKim, T., Chong, Y. P., Park, S. Y., Jeon, M., Choo, E. J., Chung, J.-W., Lee, H. K., Moon, C., Kim, D., Peck, K. R., et al. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.08.011 · Cited by 32
Cited by
Antimicrobial Resistance in ESKAPE Pathogens
De Oliveira, D. M. P., Forde, B. M., Kidd, T. J., Harris, P. N. A., Schembri, M. A., Beatson, S. A., Paterson, D. L., & Walker, M. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00181-19 · Cited by 2,078
Tamma, P. D., Heil, E. L., Justo, J. A., Mathers, A. J., Satlin, M. J., & Bonomo, R. A. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae403 · Cited by 1,191
Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges
Wong, D., Nielsen, T. B., Bonomo, R. A., Pantapalangkoor, P., Luna, B., & Spellberg, B. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-16 · Cited by 1,170
Tsuji, B. T., Pogue, J. M., Zavascki, A. P., Paul, M., Daikos, G. L., Forrest, A., Giacobbe, D. R., Viscoli, C., Giamarellou, H., Karaiskos, I., et al. (2019) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2209 · Cited by 949
Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance
Dickey, S. W., Cheung, G. Y. C., & Otto, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.23 · Cited by 799
Metadata
- Authors
- Qureshi, Z. A., Hittle, L. E., O'Hara, J. A., Rivera, J. I., Syed, A., Shields, R. K., Pasculle, A. W., Ernst, R. K., & Doi, Y.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-01-28
- Volume
- 60
- Issue
- 9
- Pages
- 1295-1303
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2138137693
- Cited by
- 395
- References
- 30
- FWCI
- 15.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.